A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61P 27/02 (2006.01)
Patent
CA 2637917
Focusing on the fact that choroidal angiogenesis is accelerated by macular subretinal inflammation, attempts are made to develop a drug which inhibits the initiation or progress of angiogenesis caused by an angiogenetic factor such as VEGF. More specifically, it is clarified that the development of choroidal angiogenesis is inhibited by administering an anti-IL-6 receptor monoclonal antibody to a mouse having been subjected to laser photocoagulation.
En se basant sur le fait que l'angiogenèse choroïdale est accélérée par une inflammation maculaire sous rétinale, on a tenté de développer un médicament qui inhibe l'initiation ou le progrès de l'angiogenèse causée par un facteur angiogénétique tel que le VEGF. Plus spécifiquement, l'invention concerne le fait que le développement d'une angiogenèse choroïdale est inhibé par l~administration d~anticorps monoclonal anti-récepteur IL6 à une souris ayant été soumise à une photocoagulation au laser.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Chugai Seiyaku Kabushiki Kaisha
Keio University
LandOfFree
Remedy for disease associated with choroidal angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Remedy for disease associated with choroidal angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Remedy for disease associated with choroidal angiogenesis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1604592